· Published by Health Canada · Official notice
These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.
U.S. Food and Drug Administration
Xiadafil VIP Tabs
SEI Pharmaceuticals / Miami, Florida, U.S.
Xiadafil VIP Tabs is promoted as an "all natural" dietary supplement used for sexual enhancement and the treatment of erectile dysfunction. The product is packaged in bottles of 8 tablets (Lot #6K029) and in blister cards of 2 tablets (Lot #6K029-SEI).
At the request of the U.S. Food and Drug Administration, U.S. federal authorities seized all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot #6K029) and blister cards of 2 tablets (Lot #6K029-SEI) because they were found to contain undeclared hydroxyhomosildenafil, a compound similar in structure to sildenafil. These lots of Xiadafil VIP Tabs have an expiration date of September 2009 (09/09).
Sildenafil is a prescription drug used for the treatment of erectile dysfunction, and should only be taken under the supervision of a health care professional.
Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.
Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.
Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.